Loading...
Conjugated NKX3.1 Rabbit mAb

C56346

Conjugated NKX3.1 Rabbit mAb

Conjugated NKX3.1 Rabbit mAb (catalogue number C56346) is a recombinant rabbit-derived conjugated primary antibody, reactive with Human samples. It targets Homeobox protein Nkx-3.1 (NKX3-1): Transcription factor, which binds preferentially the consensus sequence 5'-TAAGT[AG]-3' and can behave as a transcriptional repressor. Supplied as 100ul at ₪1,627.49; the final price is confirmed on your quote and the lot certificate of analysis ships with the order.

Conjugated Primary AntibodyHostRecombinant RabbitConjugateAF Dye
Host / source
Recombinant Rabbit
Reactivity
Human
Conjugate
AF Dye
UniProt ID
Q99801
Gene
NKX3-1
Target organism
Homo sapiens
Catalogue number
C56346
Brand
LABO Scientific
Storage
Store at 4˚Cin dark for 6 months

Target background

Target: Homeobox protein Nkx-3.1 (NKX3-1) · Homo sapiens

Transcription factor, which binds preferentially the consensus sequence 5'-TAAGT[AG]-3' and can behave as a transcriptional repressor. Plays an important role in normal prostate development, regulating proliferation of glandular epithelium and in the formation of ducts in prostate. Acts as a tumor suppressor controlling prostate carcinogenesis, as shown by the ability to inhibit proliferation and invasion activities of PC-3 prostate cancer cells

Subcellular location: Nucleus

Tissue specificity: Highly expressed in the prostate and, at a lower level, in the testis

Sequence length: 234 aa · 26350 Da

Protein background from UniProtKB, licensed under CC BY 4.0. Describes the target antigen, not this product.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Storage
Store at 4˚Cin dark for 6 months
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.